Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 812 results for "hodgkin"

Opdivo Approved in EU for Certain Advanced Classical Hodgkin's Lymphoma Patients

Opdivo Approved in EU for Certain Advanced Classical Hodgkin's...

The European Commission has approved the immunotherapy agent Opdivo (nivolumab) for the treatment of adult patients with relapsed or refractory classical Hodgkin's lymphoma (cHL) following autologous stem cell transplant (ASCT) and treatment with ..., 3 days ago
BMS hodgkin lymphoma treatment picks up EU approval Pharma Business International, 1 week ago

248 images for hodgkin

Cancer Therapy Advisor, 14 hours ago, 20 hours ago
pharmaphorum, 1 week ago
Targeted Oncology, 1 day ago
Huffington Post Black Voices, 3 days ago
ASH Clinical News, 3 days ago, 3 days ago
Blue Print, 2 weeks ago
ABC News, 3 weeks ago
ABC News, 3 weeks ago
Targeted Oncology

FDA Accepts Keytruda sBLA for Hodgkin Lymphoma Indication

Merck announced that the Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application (sBLA) for Keytruda (pembrolizumab)
 Renal & Urology News1 day ago Pembrolizumab Gets Priority Review from FDA for Hodgkin Lymphoma  Targeted Oncology1 day ago Merck's Keytruda snags second FDA 'priority' tag this week, this time in Hodgkin's  FiercePharma1 day ago Keytruda Granted Priority Review for Hodgkin Lymphoma  CURE Magazine1 day ago
The Press NZ

School haka for cancer survivor

Huntar Sammons, who was left paralysed after receiving chemotherapy for his non-Hodgkin lymphoma, is welcomed back to his school in Upper Hutt. A boy who was left paralysed after a battle with non-Hodgkins lymphoma has been welcomed back to his ...
 The Press NZ1 week ago Emotional return to Upper Hutt school for cancer survivor  Dominion Post1 week ago Watch: Moving haka delivered by schoolmates for young Upper Hutt cancer patient  ONE News1 week ago

Cornerstone Pharmaceuticals to Present New Data on CPI-613 at the American Society of Hematology 2016 Annual Meeting

New Data Highlight CPI-613 in Acute Myeloid Leukemia (AML) and Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma (T-cell NHL) CRANBURY, N.J. , Nov. 21, 2016 /PRNewswire/ -- WHAT: CPI-613 is Cornerstone Pharmaceuticals' lead drug candidate, a ...
 Benzinga.com1 week ago
Macmillan Cancer Support

PI3K signaling pathway in normal B cells and indolent B-cell malignancies

In chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphomas (NHLs), B-cell receptor signaling leads to activation of the phosphatidylinositol 3-kinase (PI3K) pathway. Idelalisib, a PI3Kδ inhibitor was approved in 2014 by the US Food and Drug ...
 Seminars In Oncology2 days ago Guest post: When life gives you lemons  Macmillan Cancer Support4 days ago Global Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Clinical Trials Review, H2, 2016  Digital Journal1 week ago B-Cell Non-Hodgkin Lymphoma H2 2016 Therapeutics Review Featuring Drug Profiles, Latest Dormant Projects, Product Development, News & Press Releases  Before It's News2 weeks ago

Forum Post: RE: Chemo and Hodgkins Lymphoma

Hi Catherine, Yes, sometimes hair grows while chemo continues, I guess it's a bit like it's trying to be normal in spite of the drugs going through your system. It may well be finer and more baby-like than your usual hair, though. As for ...
 Macmillan Cancer Support3 days ago Forum Post: Chemo and Hodgkins Lymphoma  Macmillan Cancer Support3 days ago

Forum Post: RE: Is my Lymphoma reoccurring?

Hello Jean, While I do know a bit about Lymphoma (John is the NHL expert), my expertise really is more about Hodgkin's. However I do know a bit about relapses (unfortunately refractory more than relapses) and if you really feel worried, the best ...
 Macmillan Cancer Support3 days ago Forum Post: RE: Lost my soulmate and best friend at aged 27  Macmillan Cancer Support1 week ago Forum Post: RE: Strange feeling  Macmillan Cancer Support1 week ago Forum Post: Strange feeling  Macmillan Cancer Support1 week ago
ASH Clinical News

Chronic Hepatitis B and C Virus Infection Increases Risk for Non-Hodgkin Lymphoma in Treated HIV Patients

A study published in the Annals of Internal Medicine found that HIV-infected patients receiving antiretroviral treatment (ART) who have chronic hepatitis B and C virus co-infection have an increased risk of developing non-Hodgkin lymphoma (NHL). ...
 ASH Clinical News3 days ago Global Hodgkin's Lymphoma Treatment Market & Growth, Trends and Forecasts (2016 & 2021)  MarketResearch.com4 days ago Treatment of Non-Hodgkin Lymphoma - Patent Overview (Last 5 years)  MarketResearch.com4 days ago Treatment of Hodgkin Lymphoma - Patent Overview (Last 5 years)  MarketResearch.com4 days ago

Shemar Moore's movie daughter diagnosed with Hodgkin's Lymphoma

29th Nov 16 | Entertainment News Actor Shemar Moore is raising money to help his movie daughter Nadja Alaya cover her medical bills as the teen battles cancer. Hart of Dixie star Nadja portrays Shemar's child in new romantic drama The Bounce ...
 TV3 Ireland4 days ago

Forum Post: Watch and wait or Rituximab? Newly diagnosed

Hi I was diagnosed on the 10th of Nov with non Hodgkin's lymphoma and after a ct scan I met the consultant on the 22nd. I have a 20mm lymph node in my neck and other nodes of up to 10mm in my small bowel and chest I am stage 3 with no b symptoms.
 Macmillan Cancer Support4 days ago Forum Post: RE: Watch and wait or Rituximab? Newly diagnosed  Macmillan Cancer Support4 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less